Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Aggregation of polyglutamine-expanded huntingtin exon 1 (HttEx1) in Huntington's disease (HD) proceeds from soluble oligomers to late-stage inclusions. The nature of the aggregates and how they lead to neuronal dysfunction is not well understood. We employed mass spectrometry (MS)-based quantitative proteomics to dissect spatiotemporal mechanisms of neurodegeneration using the R6/2 mouse model of HD. Extensive remodeling of the soluble brain proteome correlated with insoluble aggregate formation during disease progression. In-depth and quantitative characterization of the aggregates uncovered an unprecedented complexity of several hundred proteins. Sequestration to aggregates depended on protein expression levels and sequence features such as low-complexity regions or coiled-coil domains. In a cell-based HD model, overexpression of a subset of the sequestered proteins in most cases rescued viability and reduced aggregate size. Our spatiotemporally resolved proteome resource of HD progression indicates that widespread loss of cellular protein function contributes to aggregate-mediated toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 2×
“For quantitative analysis of the aggregate composition, we used the iBAQ (intensity-based absolute quantification) algorithm to estimate protein abundances (Schwanhäusser et al., 2011).”
MethodGenome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Although it has been reported that IBs are protective by sequestering toxic soluble oligomers (Arrasate et al., 2004; Haass and Selkoe, 2007), the substantial depletion of soluble proteins observed here suggests a major impairment of protein homeostasis in the cell.”
BackgroundProtein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334 · cited 1×
“Mass spectrometry (MS)-based quantitative proteomics is powerful technology for systems-wide analysis of complex cellular processes (Aebersold and Mann, 2016).”
BackgroundSelf-citationKato, M., Han, T. W., Xie, S., Shi, K., Du, X., Wu, L. C., Mirzaei, H., Goldsmith, E. J., Longgood, J., Pei, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.017 · Cited by 2,012 · cited 4×
“We focused on polyQ length, low-complexity regions (LCRs), and coiled-coil domains (CCDs), motifs known to modulate protein aggregation (Fiumara et al., 2010; Kato et al., 2012; Li and Li, 2004; Schaefer et al., 2012).”
BackgroundInfluentialInclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979 · cited 1×
“Although it has been reported that IBs are protective by sequestering toxic soluble oligomers (Arrasate et al., 2004; Haass and Selkoe, 2007), the substantial depletion of soluble proteins observed here suggests a major impairment of protein homeostasis in the cell.”
Background
Research works printed but not linked: 50
- Acuña, 2013, A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice, Nat. Commun., 4, 2917, 10.1038/ncomms3917 · DOI · Paper page
- Baldo, 2012, TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in Huntington’s disease, Chem. Biol., 19, 264, 10.1016/j.chembiol.2011.12.020 · DOI
- Byrne, 2016, Cerebrospinal fluid biomarkers for Huntington’s disease, J. Huntingtons Dis., 5, 1, 10.3233/JHD-160196 · DOI · Paper page
- Carapito, 2015, A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia, Mov. Disord., 30, 423, 10.1002/mds.26115 · DOI · Paper page
- Carter, 1999, Characterization of progressive motor deficits in mice transgenic for the human Huntington’s disease mutation, J. Neurosci., 19, 3248, 10.1523/JNEUROSCI.19-08-03248.1999 · DOI · Paper page
- Chen, 2013, Dopamine imbalance in Huntington’s disease: a mechanism for the lack of behavioral flexibility, Front. Neurosci., 7, 114, 10.3389/fnins.2013.00114 · DOI · Paper page
- Culver, 2012, Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis, J. Biol. Chem., 287, 21599, 10.1074/jbc.M112.359307 · DOI · Paper page
- Cumberworth, 2013, Promiscuity as a functional trait: intrinsically disordered regions as central players of interactomes, Biochem. J., 454, 361, 10.1042/BJ20130545 · DOI · Paper page
- Cummings, 2009, Alterations in cortical excitation and inhibition in genetic mouse models of Huntington’s disease, J. Neurosci., 29, 10371, 10.1523/JNEUROSCI.1592-09.2009 · DOI · Paper page
- Dalrymple, 2007, Proteomic profiling of plasma in Huntington’s disease reveals neuroinflammatory activation and biomarker candidates, J. Proteome Res., 6, 2833, 10.1021/pr0700753 · DOI · Paper page
- Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 · DOI · Paper page
- DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 · DOI · Paper page
- Doi, 2004, Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates, FEBS Lett., 571, 171, 10.1016/j.febslet.2004.06.077 · DOI · Paper page
- Dunah, 2002, Sp1 and TAFII130 transcriptional activity disrupted in early Huntington’s disease, Science, 296, 2238, 10.1126/science.1072613 · DOI · Paper page
- Fang, 2009, Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease, Mol. Cell. Proteomics, 8, 451, 10.1074/mcp.M800231-MCP200 · DOI · Paper page
- Fiumara, 2010, Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins, Cell, 143, 1121, 10.1016/j.cell.2010.11.042 · DOI · Paper page
- Galli, 2014, Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice, Nat. Commun., 5, 4992, 10.1038/ncomms5992 · DOI · Paper page
- Gerfen, 2011, Modulation of striatal projection systems by dopamine, Annu. Rev. Neurosci., 34, 441, 10.1146/annurev-neuro-061010-113641 · DOI · Paper page
- Giampà, 2010, Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington’s disease, PLoS ONE, 5, e13417, 10.1371/journal.pone.0013417 · DOI · Paper page
- Hageman, 2010, A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation, Mol. Cell, 37, 355, 10.1016/j.molcel.2010.01.001 · DOI · Paper page
- Han, 2012, Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies, Cell, 149, 768, 10.1016/j.cell.2012.04.016 · DOI · Paper page
- Hazeki, 2000, Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates, Biochem. Biophys. Res. Commun., 277, 386, 10.1006/bbrc.2000.3682 · DOI
- Hosp, 2015, Quantitative interaction proteomics of neurodegenerative disease proteins, Cell Rep., 11, 1134, 10.1016/j.celrep.2015.04.030 · DOI · Paper page
- Jain, 2016, ATPase-modulated stress granules contain a diverse proteome and substructure, Cell, 164, 487, 10.1016/j.cell.2015.12.038 · DOI · Paper page
- Jiang, 2011, Neuroprotective role of Sirt1 in mammalian models of Huntington’s disease through activation of multiple Sirt1 targets, Nat. Med., 18, 153, 10.1038/nm.2558 · DOI · Paper page
- Kaltenbach, 2007, Huntingtin interacting proteins are genetic modifiers of neurodegeneration, PLoS Genet., 3, e82, 10.1371/journal.pgen.0030082 · DOI · Paper page
- Kim, 2016, Soluble oligomers of polyQ-expanded huntingtin target a multiplicity of key cellular factors, Mol. Cell, 63, 951, 10.1016/j.molcel.2016.07.022 · DOI · Paper page
- Kroksveen, 2011, Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics, J. Proteomics, 74, 371, 10.1016/j.jprot.2010.11.010 · DOI
- Li, 2004, Huntingtin-protein interactions and the pathogenesis of Huntington’s disease, Trends Genet., 20, 146, 10.1016/j.tig.2004.01.008 · DOI · Paper page
- Li, 2013, Stress granules as crucibles of ALS pathogenesis, J. Cell Biol., 201, 361, 10.1083/jcb.201302044 · DOI · Paper page
- Martinez, 2016, Protein-RNA networks regulated by normal and ALS-associated mutant HNRNPA2B1 in the nervous system, Neuron, 92, 780, 10.1016/j.neuron.2016.09.050 · DOI · Paper page
- Meade, 2002, Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice, J. Comp. Neurol., 449, 241, 10.1002/cne.10295 · DOI · Paper page
- Mitsui, 2002, Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins, J. Neurosci., 22, 9267, 10.1523/JNEUROSCI.22-21-09267.2002 · DOI · Paper page
- Olzscha, 2011, Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions, Cell, 144, 67, 10.1016/j.cell.2010.11.050 · DOI · Paper page
- Orr, 2007, Trinucleotide repeat disorders, Annu. Rev. Neurosci., 30, 575, 10.1146/annurev.neuro.29.051605.113042 · DOI · Paper page
- Ortega, 2014, Ubiquitin-proteasome system involvement in Huntington’s disease, Front. Mol. Neurosci., 7, 77, 10.3389/fnmol.2014.00077 · DOI · Paper page
- Ossovskaya, 2004, Protease-activated receptors: contribution to physiology and disease, Physiol. Rev., 84, 579, 10.1152/physrev.00028.2003 · DOI · Paper page
- Russell, 2014, The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease, JAMA Neurol., 71, 1520, 10.1001/jamaneurol.2014.1954 · DOI
- Saudou, 2016, The biology of huntingtin, Neuron, 89, 910, 10.1016/j.neuron.2016.02.003 · DOI · Paper page
- Schaefer, 2012, Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks, Nucleic Acids Res., 40, 4273, 10.1093/nar/gks011 · DOI · Paper page
- Scheltema, 2012, SprayQc: a real-time LC-MS/MS quality monitoring system to maximize uptime using off the shelf components, J. Proteome Res., 11, 3458, 10.1021/pr201219e · DOI · Paper page
- Sharma, 2012, Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response, Mol. Cell. Proteomics, 11, 10.1074/mcp.M111.014654 · DOI · Paper page
- Shimohata, 2000, Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription, Nat. Genet., 26, 29, 10.1038/79139 · DOI · Paper page
- Stroedicke, 2015, Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity, Genome Res., 25, 701, 10.1101/gr.182444.114 · DOI
- 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E · DOI · Paper page
- Vonsattel, 1998, Huntington disease, J. Neuropathol. Exp. Neurol., 57, 369, 10.1097/00005072-199805000-00001 · DOI · Paper page
- Walther, 2011, Accurate quantification of more than 4000 mouse tissue proteins reveals minimal proteome changes during aging, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.004523 · DOI · Paper page
- Winklhofer, 2008, The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases, EMBO J., 27, 336, 10.1038/sj.emboj.7601930 · DOI · Paper page
- Woodman, 2007, The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes, Brain Res. Bull., 72, 83, 10.1016/j.brainresbull.2006.11.004 · DOI · Paper page
- Wyttenbach, 2001, Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease, Hum. Mol. Genet., 10, 1829, 10.1093/hmg/10.17.1829 · DOI · Paper page
Cited by
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642
Self-citationGlutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 371
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Bader, J. M., Geyer, P. E., Müller, J. B., Strauss, M. T., Koch, M., Leypoldt, F., Koertvelyessy, P., Bittner, D., Schipke, C. G., Incesoy, E. I., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199356 · Cited by 286
“The extensive brain atrophy apparent upon autopsy and the widespread brain proteome alterations harmonize well with the observed substantial alterations in the CSF proteome in AD and other neurodegenerative diseases (Hosp et al , 2017; preprint: Higginbotham et al , 2019).”
Self-citationThe α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure
Boyer, D. R., Li, B., Sun, C., Fan, W., Zhou, K., Hughes, M. P., Sawaya, M. R., Jiang, L., & Eisenberg, D. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917914117 · Cited by 179
Mechanisms of protein toxicity in neurodegenerative diseases
Chung, C. G., Lee, H., & Lee, S. B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2854-4 · Cited by 142
Riguet, N., Mahul-Mellier, A.-L., Maharjan, N., Burtscher, J., Croisier, M., Knott, G., Hastings, J., Patin, A., Reiterer, V., Farhan, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26684-z · Cited by 118
Urbanek, A., Popovic, M., Morató, A., Estaña, A., Elena-Real, C. A., Mier, P., Fournet, A., Allemand, F., Delbecq, S., Andrade-Navarro, M. A., et al. (2020) · Structure · doi:10.1016/j.str.2020.04.008 · Cited by 66
Aggregation and disaggregation features of the human proteome
Määttä, T. A., Rettel, M., Sridharan, S., Helm, D., Kurzawa, N., Stein, F., & Savitski, M. M. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209500 · Cited by 34
Spatiotemporal multi-omics: exploring molecular landscapes in aging and regenerative medicine
Chu, L.-X., Wang, W.-J., Gu, X.-P., Wu, P., Gao, C., Zhang, Q., Wu, J., Jiang, D.-W., Huang, J.-Q., Ying, X.-W., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00537-4 · Cited by 29
“Hosp et al. [190] utilized STP to investigate proteomic changes during the progression of Huntington’s disease (HD) in the R6/2 mouse model.”
Background
Metadata
- Authors
- Hosp, F., Gutiérrez-Ángel, S., Schaefer, M. H., Cox, J., Meissner, F., Hipp, M. S., Hartl, F.-U., Klein, R., Dudanova, I., & Mann, M.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 21
- Issue
- 8
- Pages
- 2291-2303
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2769102984
- Cited by
- 123
- References
- 18
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Munich Cluster for Systems Neurology
- European Research Council Synergy (ERC-2012-SyG_318987-ToPAG)
- Max Planck Society for the Advancement of Science
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.